{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:55:42Z","timestamp":1790924142942,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100024506","name":"Faculty of Medical Sciences, Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10911-026-09613-y","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:45:06Z","timestamp":1783597506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COX-2\u2013 and IDO-associated immunomodulatory functions of stage II carcinoma-associated fibroblasts in breast cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Ladan","family":"Langroudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair M","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahmoud","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"9613_CR1","doi-asserted-by":"publisher","first-page":"e57243","DOI":"10.7554\/eLife.57243","volume":"9","author":"RL Barrett","year":"2020","unstructured":"Barrett RL, Pur\u00e9 E. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife. 2020;9:e57243. https:\/\/doi.org\/10.7554\/eLife.57243.","journal-title":"Elife"},{"key":"9613_CR2","doi-asserted-by":"publisher","first-page":"1089068","DOI":"10.3389\/fcell.2023.1089068","volume":"11","author":"M Sarkar","year":"2023","unstructured":"Sarkar M, Nguyen T, Gundre E, Ogunlusi O, El-Sobky M, Giri B, et al. Cancer-associated fibroblasts: the chief architect in the tumor microenvironment. Front Cell Dev Biol. 2023;11:1089068. https:\/\/doi.org\/10.3389\/fcell.2023.1089068.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"9613_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-023-00236-1","volume":"15","author":"X Liu","year":"2023","unstructured":"Liu X, Li J, Yang X, Li X, Kong J, Qi D, et al. Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK\/p-paxillin\/YAP signaling. Int J Oral Sci. 2023;15(1):32. https:\/\/doi.org\/10.1038\/s41368-023-00236-1.","journal-title":"Int J Oral Sci"},{"issue":"6","key":"9613_CR4","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/cancers13061399","volume":"13","author":"RS Joshi","year":"2021","unstructured":"Joshi RS, Kanugula SS, Sudhir S, Pereira MP, Jain S, Aghi MK. The role of cancer-associated fibroblasts in tumor progression. Cancers (Basel). 2021;13(6):1399. https:\/\/doi.org\/10.3390\/cancers13061399.","journal-title":"Cancers (Basel)"},{"key":"9613_CR5","doi-asserted-by":"publisher","unstructured":"Guinn S, Perez B, Tandurella JA, Ramani M, Lee JW, Zabransky DJ, Kartalia E, Patel J, Zlomke H, Nicolson N, Shin S, Barrett B, Sun N, Hernandez A, Coyne E, Cannon C, Gross NE, Charmsaz S, Cho Y, Leatherman J, Lyman M, Mitchell J, Kagohara LT, Goggins MG, Lafaro KJ, He J, Shubert C, Burns W, Zheng L, Fertig EJ, Jaffee EM, Burkhart RA, Ho WJ, Zimmerman JW. Cancer associated fibroblasts drive epithelial to mesenchymal transition and classical to basal change in pancreatic ductal adenocarcinoma cells with loss of IL-8 expression. bioRxiv [Preprint]. 2025:2025.01.07.631784. https:\/\/doi.org\/10.1101\/2025.01.07.631784.\u00a0PMID: 39829906; PMCID: PMC11741337.","DOI":"10.1101\/2025.01.07.631784"},{"key":"9613_CR6","doi-asserted-by":"publisher","unstructured":"Kehrberg RJ, Bhyravbhatla N, Batra SK, Kumar S. Epigenetic regulation of cancer-associated fibroblast heterogeneity. Biochim Biophys Acta Rev Cancer. 2023;1878. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188901.","DOI":"10.1016\/j.bbcan.2023.188901"},{"key":"9613_CR7","doi-asserted-by":"publisher","unstructured":"Schoepp M, Str\u00f6se AJ, Haier J. Dysregulation of miRNA expression in cancer associated fibroblasts (CAFs) and its consequences on the tumor microenvironment. Cancers. 2017;9. https:\/\/doi.org\/10.3390\/cancers9060054.","DOI":"10.3390\/cancers9060054"},{"key":"9613_CR8","doi-asserted-by":"publisher","unstructured":"Langroudi L, Iranpour M, Mollaei M, Soleimani M, Hashemi SM, Hasan ZM. Stage-specific tumor microenvironment dynamics and cancer-associated fibroblast profiling in MBL-6 mouse models of breast cancer. Veterinary Sci Dev. 2025;9(1). https:\/\/doi.org\/10.4081\/vsd.2025.10069.","DOI":"10.4081\/vsd.2025.10069"},{"key":"9613_CR9","doi-asserted-by":"publisher","unstructured":"Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP et al. Carcinoma-Associated Fibroblast\u2013Like Differentiation of Human Mesenchymal Stem Cells. Cancer Res [Internet]. 2008;68(11):4331\u20139. Available from: https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0943.","DOI":"10.1158\/0008-5472.CAN-08-0943"},{"issue":"4","key":"9613_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.22034\/iji.2015.16752","volume":"12","author":"L Langroudi","year":"2015","unstructured":"Langroudi L, Hassan ZM, Soleimani M, Hashemi SM. Tumor Associated Mesenchymal Stromal Cells Show Higher Immunosuppressive and Angiogenic Properties Compared to Adipose Derived MSCs. Iran J Immunol. 2015;12(4):226\u201339. https:\/\/doi.org\/10.22034\/iji.2015.16752.","journal-title":"Iran J Immunol"},{"issue":"3","key":"9613_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1582-4934.2010.01044.x","volume":"15","author":"V Paunescu","year":"2011","unstructured":"Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, Gruia AT, et al. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med. 2011;15(3):635\u201346. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01044.x.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"9613_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res. 2023;29(6):1009\u201316. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1031.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9613_CR13","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14(1):4294. https:\/\/doi.org\/10.1038\/s41467-023-39762-1.","journal-title":"Nat Commun"},{"issue":"5","key":"9613_CR14","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.18632\/oncotarget.6740","volume":"7","author":"CJ Hanley","year":"2015","unstructured":"Hanley CJ, Noble F, Ward M, Bullock M, Drifka C, Mellone M, et al. A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget. 2015;7(5):6159. https:\/\/doi.org\/10.18632\/oncotarget.6740.","journal-title":"Oncotarget"},{"issue":"1","key":"9613_CR15","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11(1):5077. https:\/\/doi.org\/10.1038\/s41467-020-18916-5.","journal-title":"Nat Commun"},{"issue":"1","key":"9613_CR16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16(1):2175. https:\/\/doi.org\/10.1038\/s41467-025-57465-7.","journal-title":"Nat Commun"},{"key":"9613_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2019.00847","volume":"10","author":"L Gorchs","year":"2019","unstructured":"Gorchs L, Fern\u00e1ndez Moro C, Bankhead P, Kern KP, Sadeak I, Meng Q, et al. Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4\u2009+\u2009and CD8\u2009+\u2009T-cells. Front Immunol. 2019;10:847. https:\/\/doi.org\/10.3389\/fimmu.2019.00847.","journal-title":"Front Immunol"},{"issue":"1","key":"9613_CR18","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619. https:\/\/doi.org\/10.1038\/s41467-022-34395-2.","journal-title":"Nat Commun"},{"issue":"6","key":"9613_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/cancers13061399","volume":"13","author":"RS Joshi","year":"2021","unstructured":"Joshi RS, Kanugula SS, Sudhir S, Pereira MP, Jain S, Aghi MK. The role of cancer-associated fibroblasts in tumor progression. Cancers (Basel). 2021;13(6):1399. https:\/\/doi.org\/10.3390\/cancers13061399.","journal-title":"Cancers (Basel)"},{"key":"9613_CR20","doi-asserted-by":"publisher","unstructured":"Thumkeo D, Punyawatthananukool S, Prasongtanakij S, Matsuura R, Arima K, Nie H, et al. PGE2-EP2\/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment. Cell Rep. 2022;39(10). https:\/\/doi.org\/10.1016\/j.celrep.2022.110914.","DOI":"10.1016\/j.celrep.2022.110914"},{"issue":"1\u20134","key":"9613_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.prostaglandins.2011.08.005","volume":"96","author":"EP Chen","year":"2011","unstructured":"Chen EP, Smyth EM. COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat. 2011;96(1\u20134):14\u201320. https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.08.005.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"9613_CR22","doi-asserted-by":"publisher","unstructured":"Karavitis J, Hix LM, Shi YH, Schultz RF, Khazaie K, Zhang M. Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration. 2012; https:\/\/doi.org\/10.1371\/journal.pone.0046342.","DOI":"10.1371\/journal.pone.0046342"},{"issue":"1","key":"9613_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109(1):228\u201334. https:\/\/doi.org\/10.1182\/blood-2006-02-002246.","journal-title":"Blood"},{"issue":"25","key":"9613_CR24","doi-asserted-by":"publisher","first-page":"16186","DOI":"10.1073\/pnas.252464599","volume":"99","author":"W Niedbala","year":"2002","unstructured":"Niedbala W, Wei X, qing, Campbell C, Thomson D, Komai-Koma M, Liew FY. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor \u03b22 expression via cGMP. Proc Natl Acad Sci. 2002;99(25):16186\u201391. https:\/\/doi.org\/10.1073\/pnas.252464599.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"9613_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.imlet.2006.05.008","volume":"106","author":"AS L\u00f3pez","year":"2006","unstructured":"L\u00f3pez AS, Alegre E, D\u00edaz A, Mugueta C, Gonz\u00e1lez A. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2, 3-dioxygenase in human monocytic cells. Immunol Lett. 2006;106(2):163\u201371. https:\/\/doi.org\/10.1016\/j.imlet.2006.05.008.","journal-title":"Immunol Lett"},{"issue":"11","key":"9613_CR26","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00262-015-1742-0","volume":"64","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Sakakura K, Kawabata-Iwakawa R, Rokudai S, Toyoda M, Nishiyama M, et al. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2015;64(11):1407\u201317. https:\/\/doi.org\/10.1007\/s00262-015-1742-0.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"9613_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","volume":"318","author":"T Li","year":"2012","unstructured":"Li T, Yang Y, Hua X, Wang G, Liu W, Jia C, et al. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO. Cancer Lett. 2012;318(2):154\u201361. https:\/\/doi.org\/10.1016\/j.canlet.2011.12.020.","journal-title":"Cancer Lett"},{"issue":"2","key":"9613_CR28","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1038\/oncsis.2016.7","volume":"5","author":"JT Cheng","year":"2016","unstructured":"Cheng JT, Deng YN, Yi HM, Wang GY, Fu BS, Chen WJ, et al. Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation. Oncogenesis. 2016;5(2):e198\u2013198. https:\/\/doi.org\/10.1038\/oncsis.2016.7.","journal-title":"Oncogenesis"},{"key":"9613_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2019.00847","volume":"10","author":"L Gorchs","year":"2019","unstructured":"Gorchs L, Fern\u00e1ndez Moro C, Bankhead P, Kern KP, Sadeak I, Meng Q, et al. Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4\u2009+\u2009and CD8\u2009+\u2009T-cells. Front Immunol. 2019;10:847. https:\/\/doi.org\/10.3389\/fimmu.2019.00847.","journal-title":"Front Immunol"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10911-026-09613-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:49:28Z","timestamp":1790923768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10911-026-09613-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9613"],"URL":"https:\/\/doi.org\/10.1007\/s10911-026-09613-y","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical committee of the Kerman University of Medical Sciences with the reference number IR.TMU.REC.1390.326. Informed consent was obtained from all participants before the procedure.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22"}}